Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Cutis|October 26, 2020
Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumabNicholas K Mollanazar, Kevin T Savage, Bobak T Pousti, et al.Journal of the American Academy of Dermatology|February 6, 2008
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndromeCamille E Introcaso, Bizhan Micaily, Stephen K Richardson, et al.Leukemia & Lymphoma|September 28, 2011
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphomaMaria Wysocka, Noor Dawany, Bernice Benoit, et al.Journal of the American Academy of Dermatology|September 25, 2002
Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomasMichael Shapiro, Mijin Yun, Jacqueline M Junkins-Hopkins, et al.Dermatologic Therapy|December 23, 2003
The use of cytokines, fusion proteins and antibodies to treat cutaneous T-cell lymphomaAlain H Rook, Karen S McGinnis, Stephen K Richardson, et al.Cancer Research|February 19, 2008
Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cellsMichal Marzec, Krzysztof Halasa, Monika Kasprzycka, et al.Acta Dermato-Venereologica|March 5, 2020
Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis FungoidesChristina A Del Guzzo, Neha N Jariwala, Paul L Haun, et al.American Journal of Hematology|December 23, 2011
Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: implications for therapy of cutaneous T-cell lymphomaSasha Stephen, Kelly A Morrissey, Bernice M Benoit, et al.American Journal of Hematology|September 2, 2003
Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimenMichael Shapiro, Mariusz A Wasik, Jacqueline M Junkins-Hopkins, et al.Journal of the American Academy of Dermatology|October 21, 2006
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoidesMadeleine Duvic, Matthew L Sherman, Gary S Wood, et al.Pageof 13